These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 26091194)
1. A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder. Dominick K; Wink LK; McDougle CJ; Erickson CA J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):397-401. PubMed ID: 26091194 [TBL] [Abstract][Full Text] [Related]
2. Risperidone Treatment for Irritability in Fragile X Syndrome. Dominick KC; Wink LK; Pedapati EV; Shaffer R; Sweeney JA; Erickson CA J Child Adolesc Psychopharmacol; 2018 May; 28(4):274-278. PubMed ID: 29394101 [TBL] [Abstract][Full Text] [Related]
3. Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder. Yoon Y; Wink LK; Pedapati EV; Horn PS; Erickson CA J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):822-827. PubMed ID: 27389348 [TBL] [Abstract][Full Text] [Related]
4. Ziprasidone in adolescents with autism: an open-label pilot study. Malone RP; Delaney MA; Hyman SB; Cater JR J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):779-90. PubMed ID: 18315450 [TBL] [Abstract][Full Text] [Related]
5. Lurasidone for the treatment of irritability and anger in autism spectrum disorders. McClellan L; Dominick KC; Pedapati EV; Wink LK; Erickson CA Expert Opin Investig Drugs; 2017 Aug; 26(8):985-989. PubMed ID: 28685626 [TBL] [Abstract][Full Text] [Related]
6. Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole. Wink LK; Early M; Schaefer T; Pottenger A; Horn P; McDougle CJ; Erickson CA J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):78-82. PubMed ID: 24564519 [TBL] [Abstract][Full Text] [Related]
7. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder. Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985 [TBL] [Abstract][Full Text] [Related]
8. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics]. Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G; Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055 [TBL] [Abstract][Full Text] [Related]
10. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. Simpson GM; Glick ID; Weiden PJ; Romano SJ; Siu CO Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981 [TBL] [Abstract][Full Text] [Related]
11. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Keck PE; Versiani M; Potkin S; West SA; Giller E; Ice K; Am J Psychiatry; 2003 Apr; 160(4):741-8. PubMed ID: 12668364 [TBL] [Abstract][Full Text] [Related]
12. Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study. Ichikawa H; Mikami K; Okada T; Yamashita Y; Ishizaki Y; Tomoda A; Ono H; Usuki C; Tadori Y Child Psychiatry Hum Dev; 2017 Oct; 48(5):796-806. PubMed ID: 28004215 [TBL] [Abstract][Full Text] [Related]
13. Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data. Camm AJ; Karayal ON; Meltzer H; Kolluri S; O'Gorman C; Miceli J; Tensfeldt T; Kane JM CNS Drugs; 2012 Apr; 26(4):351-65. PubMed ID: 22452529 [TBL] [Abstract][Full Text] [Related]
14. Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability. Hellings JA; Reed G; Cain SE; Zhou X; Barth FX; Aman MG; Palaguachi GI; Mikhnev D; Teng R; Andridge R; Logan M; Butler MG; Han JC J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):150-9. PubMed ID: 25782098 [TBL] [Abstract][Full Text] [Related]
15. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service. Kohen I; Preval H; Southard R; Francis A Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319 [TBL] [Abstract][Full Text] [Related]
16. Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis. Fallah MS; Shaikh MR; Neupane B; Rusiecki D; Bennett TA; Beyene J J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):168-180. PubMed ID: 30707602 [TBL] [Abstract][Full Text] [Related]
17. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Owen R; Sikich L; Marcus RN; Corey-Lisle P; Manos G; McQuade RD; Carson WH; Findling RL Pediatrics; 2009 Dec; 124(6):1533-40. PubMed ID: 19948625 [TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents. Stepanova E; Dowling S; Phelps M; Findling RL Dialogues Clin Neurosci; 2017 Dec; 19(4):395-402. PubMed ID: 29398934 [TBL] [Abstract][Full Text] [Related]